Literature DB >> 7087698

Unusual urinary cholesterol metabolites following intracerebral injection of [4-14C]cholesterol into rats: I. The minor 14C-metabolite.

R B Ramsey, H J Nicholas.   

Abstract

[4-14C]Cholesterol injected intracerebrally into 10-12-day-old rats becomes localized largely in central nervous system myelin. If sufficient 14C is injected, myelin cholesterol remains labeled for the rest of the rats' lives. In the course of the slow myelin cholesterol turnover that ensues, a unique series of cholesterol metabolites is excreted exclusively in the rats' urine. There is reason to believe that the metabolites are formed in the central nervous system before entering the urine. This manuscript describes separation of the 2 urinary 14C-labeled metabolic types and isolation and identification of the minor 14C-labeled material which consists of cholesterol and 2 other sterols bound covalently to short-chain peptides. The minor sterols have been tentatively identified as 24- and 26-hydroxycholesterol. The sterol-peptide combinations have been isolated from human male urine, also.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7087698     DOI: 10.1007/BF02535114

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  8 in total

1.  The disposition of [24-3H]cerebrosterol in developing rat brain.

Authors:  Y Y Lin; L L Smith
Journal:  J Neurochem       Date:  1975-11       Impact factor: 5.372

2.  A revision of the Schoenheimer-Sperry method for cholesterol determination.

Authors:  W M SPERRY; M WEBB
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

Review 3.  Brain lipids.

Authors:  R B Ramsey; H J Nicholas
Journal:  Adv Lipid Res       Date:  1972

4.  Studies on the mechanism of demyelination: triethyl tin-induced demyelination.

Authors:  M E Smith
Journal:  J Neurochem       Date:  1973-08       Impact factor: 5.372

5.  The biosynthesis of cholesterol and other sterols by brain tissue. I. Subcellular biosynthesis in vitro.

Authors:  R B Ramsey; J P Jones; S H Naqvi; H J Nicholas
Journal:  Lipids       Date:  1971-03       Impact factor: 1.880

6.  Sterol metabolism. I. 26-Hydroxycholesterol in the human aorta.

Authors:  J E Van Lier; L L Smith
Journal:  Biochemistry       Date:  1967-10       Impact factor: 3.162

7.  Lipid composition of rat brain myelin in triethyl tin-induced edema.

Authors:  Y Eto; K Suzuki; K Suzuki
Journal:  J Lipid Res       Date:  1971-09       Impact factor: 5.922

8.  The isolation of cholest-5-ene-3beta,26-diol from human brain.

Authors:  A G Smith; J D Gilbert; W A Harland; C J Brooks
Journal:  Biochem J       Date:  1974-06       Impact factor: 3.857

  8 in total
  4 in total

Review 1.  Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future.

Authors:  Itay Raphael; Johanna Webb; Olaf Stuve; William Haskins; Thomas Forsthuber
Journal:  Expert Rev Clin Immunol       Date:  2014-12-18       Impact factor: 4.473

2.  Central nervous system demyelinating diseases and increased release of cholesterol into the urinary system of rats.

Authors:  H J Nicholas; J Taylor
Journal:  Lipids       Date:  1994-09       Impact factor: 1.880

3.  Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation.

Authors:  D Lütjohann; O Breuer; G Ahlborg; I Nennesmo; A Sidén; U Diczfalusy; I Björkhem
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

Review 4.  Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis.

Authors:  Francisco J Quintana; Ada Yeste; Howard L Weiner; Ruxandra Covacu
Journal:  J Neuroimmunol       Date:  2012-05-12       Impact factor: 3.478

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.